vs
Side-by-side financial comparison of Ametek (AME) and Organon & Co. (OGN). Click either name above to swap in a different company.
Ametek is the larger business by last-quarter revenue ($2.0B vs $1.5B, roughly 1.3× Organon & Co.). Ametek runs the higher net margin — 19.9% vs -13.6%, a 33.5% gap on every dollar of revenue. On growth, Ametek posted the faster year-over-year revenue change (13.4% vs -5.3%). Ametek produced more free cash flow last quarter ($527.3M vs $96.0M). Over the past eight quarters, Ametek's revenue compounded faster (7.3% CAGR vs -3.6%).
AMETEK, Inc. is an American multinational conglomerate and global designer and manufacturer of electronic instruments and electromechanical devices with headquarters in the United States and over 150 sites worldwide.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
AME vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.5B |
| Net Profit | $398.6M | $-205.0M |
| Gross Margin | 36.0% | 49.2% |
| Operating Margin | 25.3% | -9.8% |
| Net Margin | 19.9% | -13.6% |
| Revenue YoY | 13.4% | -5.3% |
| Net Profit YoY | 2.9% | -288.1% |
| EPS (diluted) | $1.73 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.0B | $1.5B | ||
| Q3 25 | $1.9B | $1.6B | ||
| Q2 25 | $1.8B | $1.6B | ||
| Q1 25 | $1.7B | $1.5B | ||
| Q4 24 | $1.8B | $1.6B | ||
| Q3 24 | $1.7B | $1.6B | ||
| Q2 24 | $1.7B | $1.6B | ||
| Q1 24 | $1.7B | $1.6B |
| Q4 25 | $398.6M | $-205.0M | ||
| Q3 25 | $371.4M | $160.0M | ||
| Q2 25 | $358.4M | $145.0M | ||
| Q1 25 | $351.8M | $87.0M | ||
| Q4 24 | $387.3M | $109.0M | ||
| Q3 24 | $340.2M | $359.0M | ||
| Q2 24 | $337.7M | $195.0M | ||
| Q1 24 | $310.9M | $201.0M |
| Q4 25 | 36.0% | 49.2% | ||
| Q3 25 | 36.3% | 53.5% | ||
| Q2 25 | 35.8% | 54.8% | ||
| Q1 25 | 36.1% | 55.6% | ||
| Q4 24 | 36.6% | 56.3% | ||
| Q3 24 | 36.0% | 58.3% | ||
| Q2 24 | 36.0% | 58.4% | ||
| Q1 24 | 34.1% | 59.0% |
| Q4 25 | 25.3% | -9.8% | ||
| Q3 25 | 25.8% | 15.2% | ||
| Q2 25 | 26.0% | 14.4% | ||
| Q1 25 | 26.3% | 6.7% | ||
| Q4 24 | 26.6% | 8.1% | ||
| Q3 24 | 26.1% | 13.1% | ||
| Q2 24 | 25.8% | 14.6% | ||
| Q1 24 | 24.0% | 14.5% |
| Q4 25 | 19.9% | -13.6% | ||
| Q3 25 | 19.6% | 10.0% | ||
| Q2 25 | 20.2% | 9.1% | ||
| Q1 25 | 20.3% | 5.8% | ||
| Q4 24 | 22.0% | 6.8% | ||
| Q3 24 | 19.9% | 22.7% | ||
| Q2 24 | 19.5% | 12.1% | ||
| Q1 24 | 17.9% | 12.4% |
| Q4 25 | $1.73 | $-0.78 | ||
| Q3 25 | $1.60 | $0.61 | ||
| Q2 25 | $1.55 | $0.56 | ||
| Q1 25 | $1.52 | $0.33 | ||
| Q4 24 | $1.67 | $0.42 | ||
| Q3 24 | $1.47 | $1.38 | ||
| Q2 24 | $1.45 | $0.75 | ||
| Q1 24 | $1.34 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $458.0M | $574.0M |
| Total DebtLower is stronger | $2.3B | $8.6B |
| Stockholders' EquityBook value | $10.6B | $752.0M |
| Total Assets | $16.1B | $12.9B |
| Debt / EquityLower = less leverage | 0.21× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $458.0M | $574.0M | ||
| Q3 25 | $439.2M | $672.0M | ||
| Q2 25 | $619.7M | $599.0M | ||
| Q1 25 | $399.0M | $547.0M | ||
| Q4 24 | $374.0M | $675.0M | ||
| Q3 24 | $396.3M | $763.0M | ||
| Q2 24 | $396.6M | $704.0M | ||
| Q1 24 | $373.8M | $575.0M |
| Q4 25 | $2.3B | $8.6B | ||
| Q3 25 | — | $8.8B | ||
| Q2 25 | — | $8.9B | ||
| Q1 25 | — | $9.0B | ||
| Q4 24 | $2.1B | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | $10.6B | $752.0M | ||
| Q3 25 | $10.5B | $906.0M | ||
| Q2 25 | $10.4B | $733.0M | ||
| Q1 25 | $10.0B | $542.0M | ||
| Q4 24 | $9.7B | $472.0M | ||
| Q3 24 | $9.6B | $493.0M | ||
| Q2 24 | $9.3B | $144.0M | ||
| Q1 24 | $9.0B | $48.0M |
| Q4 25 | $16.1B | $12.9B | ||
| Q3 25 | $16.2B | $13.6B | ||
| Q2 25 | $15.3B | $13.5B | ||
| Q1 25 | $14.9B | $13.2B | ||
| Q4 24 | $14.6B | $13.1B | ||
| Q3 24 | $14.8B | $12.8B | ||
| Q2 24 | $14.8B | $12.2B | ||
| Q1 24 | $14.9B | $11.9B |
| Q4 25 | 0.21× | 11.49× | ||
| Q3 25 | — | 9.74× | ||
| Q2 25 | — | 12.14× | ||
| Q1 25 | — | 16.52× | ||
| Q4 24 | 0.22× | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $584.3M | $141.0M |
| Free Cash FlowOCF − Capex | $527.3M | $96.0M |
| FCF MarginFCF / Revenue | 26.4% | 6.4% |
| Capex IntensityCapex / Revenue | 2.9% | 3.0% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.7B | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $584.3M | $141.0M | ||
| Q3 25 | $440.9M | $264.0M | ||
| Q2 25 | $359.1M | $220.0M | ||
| Q1 25 | $417.5M | $75.0M | ||
| Q4 24 | $550.0M | $390.0M | ||
| Q3 24 | $487.2M | $141.0M | ||
| Q2 24 | $381.4M | $332.0M | ||
| Q1 24 | $410.2M | $76.0M |
| Q4 25 | $527.3M | $96.0M | ||
| Q3 25 | $420.0M | $218.0M | ||
| Q2 25 | $329.8M | $181.0M | ||
| Q1 25 | $394.5M | $43.0M | ||
| Q4 24 | $498.3M | $335.0M | ||
| Q3 24 | $460.9M | $99.0M | ||
| Q2 24 | $360.0M | $300.0M | ||
| Q1 24 | $382.6M | $30.0M |
| Q4 25 | 26.4% | 6.4% | ||
| Q3 25 | 22.2% | 13.6% | ||
| Q2 25 | 18.5% | 11.4% | ||
| Q1 25 | 22.8% | 2.8% | ||
| Q4 24 | 28.3% | 21.0% | ||
| Q3 24 | 27.0% | 6.3% | ||
| Q2 24 | 20.8% | 18.7% | ||
| Q1 24 | 22.0% | 1.8% |
| Q4 25 | 2.9% | 3.0% | ||
| Q3 25 | 1.1% | 2.9% | ||
| Q2 25 | 1.6% | 2.4% | ||
| Q1 25 | 1.3% | 2.1% | ||
| Q4 24 | 2.9% | 3.5% | ||
| Q3 24 | 1.5% | 2.7% | ||
| Q2 24 | 1.2% | 2.0% | ||
| Q1 24 | 1.6% | 2.8% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | 1.19× | 1.65× | ||
| Q2 25 | 1.00× | 1.52× | ||
| Q1 25 | 1.19× | 0.86× | ||
| Q4 24 | 1.42× | 3.58× | ||
| Q3 24 | 1.43× | 0.39× | ||
| Q2 24 | 1.13× | 1.70× | ||
| Q1 24 | 1.32× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AME
| Transferred At Point In Time | $1.1B | 54% |
| Electronic Instruments Group | $620.1M | 31% |
| Transferred Over Time | $294.6M | 15% |
OGN
Segment breakdown not available.
